Fig. 3.
Mean plasma trough concentrations of VPA (63.3±5.7 μg/mL), 2-ene-VPA (5.3±0.4 μg/mL) and 4-ene-VPA (0.050±0.0035 μg/mL) in epilepsy patients (n=60) after oral administration of Debakin at 0.5 g twice daily.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.